Skip to content


  • Poster presentation
  • Open Access

Exploring Kaposi's sarcoma-associated herpesvirus latent genes' role in viral lymphomagenesis using transgenic mice

  • 1,
  • 1 and
  • 1
Infectious Agents and Cancer20094 (Suppl 2) :P39

  • Published:


  • Sarcoma
  • Transgenic Mouse
  • Cell Activation
  • Latent Gene
  • Germinal Center

Kaposi's sarcoma-associated herpesvirus (KSHV) is a human lymphotropic gammaherpesvirus and associated with Kaposi sarcoma as well as two B cell lymphoproliferative disorders: primary effusion lymphoma (PEL) and multicentric Castleman disease. We reported that the KSHV latency-associated nuclear antigen (LANA) transgenic mice developed splenic follicular hyperplasia and showed increased germinal center formation. Here we report that the KSHV LANA-induced B cell activation is CD19 dependent and LANA restores the marginal zone defect in CD19-/- mice. To test KSHV latent genes' role in viral lymphomagenesis, we generated mice expressing all KSHV latency-associated genes. All of the transgenic mice induced mature B cell activation. Further characterization of the mice expressing all KSHV latency-associated genes is currently underway.

Authors’ Affiliations

Department of Microbiology and Immunology and Lineberger comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA


© Sin et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.